Ambit is an analytics and technology-enabled services company that allows biopharma to adapt to the challenges and opportunities in the rare and specialty disease markets.
Ambit’s modular approach can address barriers to locate, engage, activate, and/or diagnose rare disease patients for clinical trials and approved products.
Ambit is a future-focused partner for biopharma with the deep expertise needed to tackle challenges in rare and specialty disease.
Our brand may be changing, but our focus remains the same. We are committed to developing novel solutions that enable our biopharma clients to adapt to the challenges and opportunities in the rare and specialty disease markets.
